APA (7th ed.) Citation

EJ, C., FE, L., O, F., M, P., G, S., H, W., . . . LM, K. (2009). Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. Journal of immunology (Baltimore, Md. : 1950), 183(10), 6338. https://doi.org/10.4049/jimmunol.0901373

Chicago Style (17th ed.) Citation

EJ, Collarini, et al. "Potent High-affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients." Journal of Immunology (Baltimore, Md. : 1950) 183, no. 10 (2009): 6338. https://doi.org/10.4049/jimmunol.0901373.

MLA (9th ed.) Citation

EJ, Collarini, et al. "Potent High-affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients." Journal of Immunology (Baltimore, Md. : 1950), vol. 183, no. 10, 2009, p. 6338, https://doi.org/10.4049/jimmunol.0901373.

Warning: These citations may not always be 100% accurate.